Vinay Prasad oversees vaccines, gene therapies and the blood supply. His views raise alarms for pharmaceutical companies and ...

Harvey Jones says investment brokers showed their love for AstraZeneca shares at the start of the year, but maybe wondering if that's been reciprocated. The post 21 analysts advised buy AstraZeneca ...

The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.

Axon named Tina Hahn as president and managing partner. Bristol Myers Squibb promoted Cari Gallman to EVP, general counsel ...

Under Robert F. Kennedy Jr, the FDA has purged public health information on vaccines, contraception, HIV, and more. Internal ...

A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.

From claiming COVID vaccines were perfect and would end the pandemic to treating rare, temporary vaccine side-effects, even ...

Matthew Herper joins Adam and Allison to examine Prasad’s appointment and the band of outsiders now in charge of U.S. health ...

Now the “MAHA” takeover of the federal health agencies is all but complete. Earlier today, Trump told reporters that he ...

FDA commissioner Marty Makary told FDA staff in an email that Prasad, “brings a great set of skills, energy, and competence ...

Republicans on Capitol Hill are struggling to reach consensus on cutting the Medicaid program as they search for nearly a ...

What does the appointment of Vinay Prasad as the head of biologic drug evaluation mean for biotechs? Is his fiery public ...